Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
Case report

Indian Pediatr 2015;52: 152-154

Recurrent Kawasaki Disease

 

Pramila Verma, Neeti Agarwal and Mahesh Maheshwari

From Department of Pediatrics, People’s College of Medical Sciences & RC, Bhanpur, Bhopal, India.

Correspondence to: Dr Pramila Verma, Associate Professor Department of Pediatrics, Sr MIG-B-10, Peoples campus, Bhanpur, Bhopal India.
Email: [email protected]

Received: July 14, 2014;
Initial review: August 21, 2014;
Accepted: December 06, 2014.

 

 

Background: Recurrent Kawasaki disease is rare. Case characteristics: An eight-month old infant had classic Kawasaki disease with transient coronary artery dilatation. Observations: Recurrence of incomplete Kawasaki disease after two years of initial diagnosis. Outcome: The index episode of Kawasaki disease was resistant to single infusion of immunoglobulin, while repeat episode responded within 24 hours of institution of therapy. Message: Early recognition of recurrent Kawasaki disease requires a high index of suspicion.

Keywords: Incomplete Kawasaki disease, Outcome, Recurrence, Resistant.



K
awasaki disease (KD) is an acute, self-limiting, medium-size vessel vasculitis of unknown etiology that predominantly involves the skin, mucous membranes, lymph nodes and coronary arteries. Standard therapy of KD is with a single intravenous infusion of immunoglobulins (IVIG) and high-dose aspirin until the acute phase reactants normalize. IVIG-resistant KD, which occurs in approximately 15% of children, can be defined as the persistence of fever beyond 36 hours of the initial IVIG infusion, and mandates a 2nd or even 3rd dose of IVIG [1-3]. Recurrent KD is mostly reported in Japan and the US, occurring in 3-4% and 0.8% of cases, respectively [4], but is only rarely reported from India [5].

Case Report

An 8-month-old boy was referred to us with cough and cold for 15 days, fever for 5 days, and loose motions for 2 days. On examination, he was irritable and febrile. He had tachypnea and tachycardia with normal blood pressure. His eyes and oral mucosa were injected, and he had strawberry tongue. His hands and feet were edematous. Systemic examination was unremarkable. The BCG scar mark was inflamed.

Hematological investigations revealed hemoglobin (Hb) 7.5 g/dL, total leucocyte count (TLC) 36.8×109/L, P:76%, L:22%, platelet count 400x109/L, C-reactive protein (CRP) 12 mg/dL, erythrocyte sedimentation rate (ESR) 38 mm/h, aspartate aminotransferase (AST) 15.6 U/L, alanine aminotransferase (ALT) 10.0 U/L, serum sodium 137 meq/L, potassium 3.6 meq/L, serum albumin 2.3 g/dL, blood urea 25.2 mg/dL, and serum creatinine 0.72 mg/dL. Routine microscopy of urine and cerebrospinal fluid was normal. Antistreptolysin O (ASO) titer and Mantoux test were negative. Malarial parasites were not seen in smear. Chest X-ray showed cardiomegaly. Abdominal ultrasound was normal. He received injections of ceftriaxone, amikacin, metronidazole and gatifloxacin for four days before being referred to us. In our hospital, injections of meropenem, vancomycin and artesunate were administered empirically. Inspite of 10 days therapy, fever was unresponsive, and the child was provisionally diagnosed as KD. Two-dimensional echocardiography (2D-Echo) revealed left coronary artery dilatation (6.9 mm), no fistula, and mild pericardial effusion with ejection fraction of 60%. Subsequently, IVIG (2 g/Kg stat dose) and aspirin (85 mg/kg/day in divided doses) were administered. Fever was persistent even after 36 hours of IVIG, in view of resistant KD; a second dose of IVIG was given [2]. Consequently fever subsided within 24 hours of the second dose of IVIG. Aspirin was prescribed at high doses till acute phase reactants normalized (7 weeks), following which the dose was tapered to 5 mg/kg/day. Echocardiography at 4 months revealed reduction in left coronary artery dilation (3.4 mm) that completely resolved at 9 months; aspirin was stopped subsequently.

The child again presented at three years of age (after 2 years of first episode) with fever for four days, pain in legs and swelling of hands and feet for two days. He had no history of cold, cough, allergy, insect bite or drug intake. On examination, the child was febrile and irritable with tachycardia and normal blood pressure. His oral mucosa, tongue and pharynx were diffusely injected; ulcers, enanthem and exudates were not noted. Right sided cervical lymphadenopathy (>1.5 cm) along with dry, crusted and cracked lips were present. Edema was noted over hands and feet. Skin examination did not revealed eruptions or rashes. Rest of the systemic examination was normal.

Laboratory tests revealed Hb 8.7 g/dL, TLC 16.8 ×109/L with 73% neutrophils, platelet count 521×109/L, serum albumin 3.2 g/dL, AST 154.0 U/L, ALT 159.7 U/L, ESR 48.0 mm/h, CRP 4.8 mg/dL, Serum sodium 128 meq/L and potassium 3.9 meq/L; ASO titer was negative. Peripheral smear for malarial parasite and Mantoux test were negative. Blood culture was sterile. Renal function tests and routine microscopic examination of urine was normal. Chest X-ray and abdominal ultrasound was normal. The child was administered intravenous ceftriaxone, oral antihistaminics and antipyretics. Despite 72 hours of therapy, fever persisted and there was worsening of oral mucosal congestion and swelling of extremities. Widal and malaria antigen tests were negative. Subsequently, child developed periungal desquamation of fingers, and the child was diagnosed as recurrent KD with incomplete presentation (>5d fever along with 3 clinical criteria: changes of mucosae of oropharynx, cervical lymphadenopathy and changes of peripheral extremities). Concomitant echocardiogram revealed normal coronary arteries. On the 7th day of fever, the child was administered with IVIG (2 g/Kg/day) and aspirin (80 mg/Kg/day) in three divided doses. Defervescence was achieved within 24 hours and remaining features improved over next 2 days. Follow-up after 15 days revealed desquamation of skin of both soles (Fig. 1). Skin peeling was in sheets and vastly intense to involve the entire sole, which further substantiated our diagnosis. Coronary arterial abnormalities (CAA) were not noted in 2D-echo at 6 weeks, 6 months and 12 months follow-up. The child is being followed up regularly for the last four years without any symptoms.

Fig. 1 Desquamation of skin over the soles during second episode of Kawasaki disease. (Color image at website)

Discussion

KD presents with classic or incomplete manifestations and is diagnosed after excluding similar disease conditions with the help of clinical criteria proposed by the American Heart Association [3]. The differential diagnosis of KD includes viral infections (measles, adenovirus, rubella, erythema infectiosum, infectious mononucleosis and herpangina) which shares acute oro-pharyngitis, fever and cervical adenopathy but with less evidence of systemic inflammation and lack the extremity changes as seen in KD. Systemic onset juvenile idiopathic arthritis mimics KD but lack of arthritis in the child over long term follow up excluded it. Absence of skin rashes negated scarlet fever, rickettsial infections and polyarteritis nodosa. The blood pressure was normal, ruling out streptococcal toxic-shock syndrome. Thus, we diagnosed the case as recurrent KD with incomplete presentation, which was supported by laboratory reports. Sheetlike skin peeling is pathognomonic of KD and additionally supported our diagnosis [2]. Both the episodes responded well to IVIG. However, the initial episode was resistant to the single infusion of IVIG and responded only after repeat dose [1]. If the symptoms of KD persist or recur after IVIG therapy, macrophage activation syndrome as a complication of KD should be considered. However it was excluded, as hepatosplenomegaly and pancytopenia were not noted in the child during entire course of illness.

The risk factors predictive of recurrent KD in a child are: younger age (£2 years) at the onset, male sex, treatment with IVIG [6,7], longer durations of fever, lower hemoglobin levels [8] and presence of CAA at the first episode [4,9]. All these risk factors for recurrence at the first episode were present in our case as well. High levels of transaminitis at first episode also poses risk for recurrent KD but were normal in our patient.

Hirata, et al. [8] reported recurrence of KD within a year while, the present case had recurrence after two years of first episode. Recurrence of KD and Incomplete KD are generally associated with CAA [2,3]; however, this was not seen in our case. Kato, et al. [2] reported CAA occurrence in 20% children of untreated KD in Japan. Daniels, et al. [10] reported that undiagnosed or partially treated KD in childhood contributes CAA in 5% of adults in the USA.

Kawasaki disease should be included in the differential diagnosis of fever unresponsive to appropriate therapy, as all the criteria may not appear simultaneously but emerge serially, more so in a child with previous history of Kawasaki disease.

Contributors: PV: Literature search and review, manuscript review, manuscript editing, drafting the article and patient management. She will act as guarantor; NA: Editing the manuscript, managed the patient and revising the article critically for important intellectual content; MM: Acquisition and interpretation of data, managed the patient and edited the manuscript. All authors have approved the final manuscript.

Funding: None; Competing interests: None stated.

Reference

1. Singh S, Kawasaki T. Kawasaki disease - An Indian perspective. Indian Pediatr. 2009;46:563-71.

2. Son MB, Newburger JW. Kawasaki Disease. In: Kliegman RM, Stanton BF, Geme JW, Schor NF editors. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Elsevier; 2011. p. 862-7.

3. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. American Heart Association Scientific Statement  Diagnosis, treatment, and long-term management of Kawasaki disease: Circulation. 2004;110:2747-71.

4. Yang HM, Du ZD, Fu PP. Clinical features of recurrent Kawasaki disease and its risk factors. Eur J Pediatr. 2013;172:1641-7.

5. Balasubramanian S, Ganesh R. Recurrent kawasaki disease. Indian J Pediatr. 2009;76:848-9.

6. Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Tanihara S, Oki I, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics. 1998;102:65.

7. Nakamura Y, Hirose K, Yanagawa H, Kato H, Kawasaki T. Incidence rate of recurrent Kawasaki disease in Japan. Acta Paediatr. 1994;83:1061-4.

8. Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: From the results of nationwide surveys of Kawasaki Disease in Japan. Acta Paediatr. 2001;90:40-4.

9. Chen CY, Wu JR. Relapse of Kawasaki disease: A case report. Gaoxiong Yi, Xue Ke, Xue Za Zhi. 1989;5:189-93.

10. Daniels LB, Tjajadi MS, Walford HH, Jimenez-Fernandez S, Trofimenko V, Fick DB, et al. Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia: Clinical perspective. Circulation. 2012;125:2447-53.

 

Copyright © 1999-2014 Indian Pediatrics